Immunohistochemical description of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human labia minora

Journal of Sexual Medicine

Volumn 4, Issue 3, 2007, Pages 602-608

  Ückert, Stefan ^a,b   Oelke, Matthias ^c   Albrecht, Knut ^a   Stief, Christian ^d   Jonas, Udo ^a   Hedlund, Petter ^e  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b IPF PHARMACEUTICALS GMBH   (Germany)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Immunohistochemistry; Labia minora; Phosphodiesterase isoenzymes

Indexed keywords

CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; FLUOROCHROME; PHOSPHODIESTERASE; PHOSPHODIESTERASE I; PHOSPHODIESTERASE III; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE V; PHOSPHODIESTERASE X; PHOSPHODIESTERASE XI; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD FLOW; CADAVER; ENZYMATIC DEGRADATION; ENZYME ACTIVITY; EPITHELIUM; FEMALE; FEMALE GENITAL SYSTEM; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEYDIG CELL; NEUROSECRETORY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEBACEOUS GLAND; TISSUE BLOOD FLOW; TISSUE DISTRIBUTION; VAGINA; VASCULAR SMOOTH MUSCLE; VASCULAR TISSUE;

EID: 34249102899     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2007.00490.x     Document Type: Article

References (30)

1. Nappi R, Salonia A, Traish AM, van Lunsen RH, Vardi Y, Kodiglu A, Goldstein I. Clinical biologic pathophysiologies of women's sexual dysfunction. J Sex Med 2005;2:4-25.
2. Basson R, Brotto LA, Laan E, Redmond G, Utian WH. Assessment and management of women's sexual dysfunctions: Problematic desire and arousal. J Sex Med 2005;2:291-300.
3. Ückert S, Oelke M, Waldkirch E, Stief CG, Albrecht K, Tröger HD, Jonas U, Andersson KE, Hedlund P. Cyclic adenosine monophosphate and cyclic guanosine monophosphate phospho-diesterase isoenzymes in human vagina: Relation to nitric oxide synthase isoforms and vasoactive intestinal polypeptide-containing nerves. Urology 2005;65:604-10.
4. D'Amati G, Di Giola CR, Bologna M, Giordano D, Giorgi M, Dolci S, Jannini EA. Type 5 phosphodiesterase expression in the human vagina. Urology 2002;60:191-5.
5. Oelke M, Hedlund P, Albrecht K, Ellinghaus P, Stief CG, Jonas U, Andersson KE, Ückert S. Expression of cAMP- and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: Immunohistochemical and molecular biology study. Urology 2006;67:1111-6.
6. Taher A, Meyer M, Stief CG, Jonas U, Forssmann WG. Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle. World J Urol 1997; 15:32-5.
7. Stief CG, Taher A, Meyer M, Schulz-Knappe P, Becker AJ, Truss MC, Ückert S, Forssmann WG, Jonas U. Phosphodiesterase isoenzymes in human ureteral smooth muscle: Identification, characterization, and functional effects of various phosphodiesterase inhibitors in vitro. Urol Int 1995;55:183-9.
8. Truss MC, Ückert S, Stief CG, Kuczyk MA, Jonas U. Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in human detrusor smooth muscle: I. Identification and characterization. Urol Res 1996;24:123-8.
9. Ückert S, Küthe A, Jonas U, Stief CG. Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate. J Urol 2001;166:2484-90.
10. Park K, Moreland RB, Goldstein I, Atala A, Traish A. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle. Biochem Biophys Res Comm 1998;49:612-7.
11. Jeon YH, Heo YS, Kim CN, Hyun YL, Lee TG, Ro S, Cho JM. Phosphodiesterase: Overview of protein structures, potential therapeutic applications and recent progress in drug development. Cell Mol Life Sci 2005;62:1198-220.
12. Farooqui SM, Brock JW, Hamdi A, Prasad C. Antibodies against synthetic peptides predicted from the nucleotide sequence of D2 receptor recognize native dopamine receptor protein in rat striatum. J Neurochem 1991;57:1363-9.
13. Farooqui SM, Al-Bagdadi F, Houslay MD, Bolger GB, Stout R, Specian RD, Cherry JA, Conti M, O'Donnell JM. Surgically induced cryptorchidism-related degenerative changes in spermatogonia are associated with loss of cyclic adenosine monophosphate-dependent phosphodiesterases type 4 in abdominal testes of rats. Biol Reprod 2001;64:1583-9.
14. Müller T, Engels P, Fozard JP. Subtypes of type 4 cAMP phosphodiesterases: Structure, regulation and selective inhibition. Trends Plant Sci 1996;17:294-8.
15. Hidden G, Lassau JP, Delmas A. Arterial vascularization of the labia majora and labia minora. C R Assoc Anat 1970;147:282-4.
16. Rupec M, Hoffmeister H. Electron microscopical studies on the development of lipid drops in the free sebaceous glands of labia minora. Arch Gynäkol 1968;205:368-75.
17. Suh DD, Yang CC, Cao Y, Garland PA, Maravilla KR. Magnetic resonance imaging anatomy of the female genitalia in premenopausal and postmenopausal women. J Urol 2003;170:138-44.
18. Pessina MA, Hoyt RF Jr, Goldstein I, Traish AM. Differential regulation of the expression of estrogen, progesterone, and androgen receptors by sex steroid hormones in the vagina: Immunohistochemical studies. J Sex Med 2006;3:804-14.
19. Truss MC, Stief CG, Ückert S, Becker AJ, Wefer J, Schultheiss D, Jonas U. Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: From bench to bedside. World J Urol 2001;19:344-50.
20. Sairam K, Kulinskava E, McNicholas TA, Boustead GB, Hanbury D. Sildenafil influences lower urinary tract symptoms. BJU Int 2002;90:836-9.
21. McVary KT, Roehrborn CG, Kaminetsky JC, Auerbach SM, Wachs B, Young JM, Esler A, Sides GD, Denes BS. The efficacy and safety of tadalafil administration once a day for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH). Eur Urol 2006;5:196 (Abstract).
22. Vemulapalli S, Kurowski S. Sildenafil relaxes rabbit clitoral corpus cavernosum. Life Sci 2000;67:23-9.
23. Ückert S, Ehlers V, Nüser V, Oelke M, Kauffels W, Scheller F, Jonas U. In vitro functional responses of isolated human vaginal tissue to selective phosphodiesterase inhibitors. World J Urol 2005;23:398-404.
24. Berman JR, Berman LA, Lin H, Flaherty E, Lahey N, Goldstein I, Cantey-Kiser J. Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder. J Sex Marital Ther 2001;27:411-20.
25. Basson R, Brotto LA. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: A randomised controlled trial. BJOG 2003;110:1014-24.
26. Dasgupta R, Wiseman OJ, Kanabar G, Fowler CJ, Mikol DD. Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis. J Urol 2004;171:1189-93.
27. Zhu J, Mix E, Winblad B. The anti-depressant and anti-inflammatory effects of rolipram in the central nervous system. CNS Drug Rev 2001;7:387-98.
28. Wachtel H. Potential antidepressant activity of rolipram and other selective cyclic adenosine 3',5',-monophosphate phosphodiesterase inhibitors. Neuropharmacology 1983;22:267-72.
29. Chujor CS, Hammerschmid F, Lam C. Cyclic nucleotide phosphodiesterase 4 subtypes are differentially expressed by primary keratinocytes and human epidermoid cell lines. J Invest Dermatol 1998;110:287-91.
30. Chan SC, Reifsnyder D, Beavo JA, Hanifin JM. Immunochemical characterization of the distinct monocyte cyclic AMP-phosphodiesterase from patients with atopic dermatitis. J Allergy Clin Immunol 1993;91:1179-88.